Eli Lilly has partnered a leading USA-approved GMP supplier to produce its groundbreaking medications, Retatrutide and Tirzepatide. This strategic decision demonstrates Lilly's commitment to excellence in manufacturing and ensures patients with access to safe and effective treatments. The chosen partner possesses a proven track record of adherence